EP2844274
PHARMACEUTICAL COMPOSITION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.5.2013EP published:
20.3.2019EP application number:
13721650.3
EPO information:
European Patent Register
Max expiry date:
30.4.2033
Title:
PHARMACEUTICAL COMPOSITION
Timeline
Today
1.5.2013EP application
20.3.2019EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
JOHANSEN, ThueAddress:
Bagsværd, DK
Name:
MERSEBACH, HenrietteAddress:
Bagsværd, DK
Name:
AXELSEN, MadsAddress:
Bagsværd, DK
Name:
LANGE, MartinAddress:
Bagsværd, DK
Priority
Number:
12166252Date:
1.5.2012Country:
EP
Number:
12166251Date:
1.5.2012Country:
EP
Number:
201261641540 PDate:
2.5.2012Country:
US
Number:
201261641544 PDate:
2.5.2012Country:
US
Classification
Categories:
A61K 38/28